FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesisQiqiao Du, Shuzhong Yao|Cell Death and Disease|2022Cited by 128
miR‑149‑5p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathwayManman Xu, Shuzhong Yao|International Journal of Oncology|2018Cited by 53
Tyrosine catabolism enhances genotoxic chemotherapy by suppressing translesion DNA synthesis in epithelial ovarian cancerJie Li, Chaoyun Pan, Yangyang Chen et al.|Cell Metabolism|2023Cited by 44
Figure S1-S4, Table S1-S7 from An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline <i>BRCA1/2</i> Mutation and Platinum-sensitive Recurrent Ovarian CancerNing Li, Lingying Wu, Hualei Bu et al.|Unknown|2023Cited by 0
Figure S1-S4, Table S1-S7 from An Open-label, Multicenter, Single-arm, Phase II Study of Fluzoparib in Patients with Germline <i>BRCA1/2</i> Mutation and Platinum-sensitive Recurrent Ovarian CancerNing Li, Lingying Wu, Hualei Bu et al.|Unknown|2023Cited by 0